RE-BVS – Piemonte Repository

Sfoglia per AUTORE
HARRISON C
Collezione AOU Alessandria

Items : 3

Phase 2 study of the lysine-specific demethylase 1 inhibitor bomedemstat for essential thrombocythemia. in Blood advances / Blood Adv. 2026 May 26;10(10):3494-3504. doi: 10.1182/bloodadvances.2025017575.

2026
AOU Alessandria

Gill H; Palandri F; Ross DM; Göthert JR; Cochrane T; Larsen SR; Halpern AB; Shortt J; Rossetti JM; Liang J; Marchetti M; Wilson AJ; Innes AJ; Hanna M; Vianelli N; Stevenson WS; Vannucchi AM; Kleppe M; Flynn J; Natsoulis G; Harrison CN; Rienhoff HY Jr;

The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 study. in Blood advances / Blood Adv. 2026 Jul 14;10(13):4585-4594. doi: 10.1182/bloodadvances.2025018141.

2026
AOU Alessandria

Gill H; Yacoub A; Gerds AT; Shortt J; Rossetti JM; Mead AJ; Göthert JR; Koschmieder S; Ewing J; Halpern AB; Palandri F; Passamonti F; Mesa R; Marchetti M; Harrison C; Vannucchi AM; Watts JM; Wood JC; Ross DM; Peppe J; Natsoulis G; Rienhoff HY Jr;

Appropriate management of polycythaemia vera with cytoreductive drug therapy: European LeukemiaNet 2021 recommendations. in The Lancet. Haematology / Lancet Haematol. 2022 Apr;9(4):e301-e311. doi: 10.1016/S2352-3026(22)00046-1.

2022
AOU Alessandria

Marchetti M; Vannucchi AM; Griesshammer M; Harrison C; Koschmieder S; Gisslinger H; Álvarez-Larrán A; De Stefano V; Guglielmelli P; Palandri F; Passamonti F; Barosi G; Silver RT; Hehlmann R; Kiladjian JJ; Barbui T;